Correlation Between Aequus Pharmaceuticals and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aequus Pharmaceuticals and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aequus Pharmaceuticals and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aequus Pharmaceuticals and Rezolute, you can compare the effects of market volatilities on Aequus Pharmaceuticals and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aequus Pharmaceuticals with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aequus Pharmaceuticals and Rezolute.

Diversification Opportunities for Aequus Pharmaceuticals and Rezolute

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aequus and Rezolute is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Aequus Pharmaceuticals and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and Aequus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aequus Pharmaceuticals are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of Aequus Pharmaceuticals i.e., Aequus Pharmaceuticals and Rezolute go up and down completely randomly.

Pair Corralation between Aequus Pharmaceuticals and Rezolute

Assuming the 90 days horizon Aequus Pharmaceuticals is expected to under-perform the Rezolute. In addition to that, Aequus Pharmaceuticals is 1.27 times more volatile than Rezolute. It trades about -0.09 of its total potential returns per unit of risk. Rezolute is currently generating about 0.06 per unit of volatility. If you would invest  403.00  in Rezolute on August 29, 2024 and sell it today you would earn a total of  96.00  from holding Rezolute or generate 23.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aequus Pharmaceuticals  vs.  Rezolute

 Performance 
       Timeline  
Aequus Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aequus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Rezolute 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile essential indicators, Rezolute may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Aequus Pharmaceuticals and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aequus Pharmaceuticals and Rezolute

The main advantage of trading using opposite Aequus Pharmaceuticals and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aequus Pharmaceuticals position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind Aequus Pharmaceuticals and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format